Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium “Long-Acting Injectables” Working GroupAndrea Bauer, Stephanie E. Barrett, Philippe Berben et al.|Pharmaceutical Research|2023Cited by 64
Pharmacokinetics, Disposition, and Biotransformation of [14C]Lenacapavir, a Novel, First-in-Class, Selective Inhibitor of HIV-1 Capsid Function, in Healthy Participants Following a Single Intravenous InfusionElijah Weber, Renu Singh, John Ling et al.|Clinical Pharmacokinetics|2024Cited by 17